GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Inventories, Raw Materials & Components

Kaken Pharmaceutical Co (TSE:4521) Inventories, Raw Materials & Components : 円7,347 Mil (As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Inventories, Raw Materials & Components?

Kaken Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Dec. 2023 was 円7,347 Mil.

Kaken Pharmaceutical Co's quarterly raw materials increased from Jun. 2023 (円7,029 Mil) to Sep. 2023 (円7,165 Mil) and increased from Sep. 2023 (円7,165 Mil) to Dec. 2023 (円7,347 Mil).

Kaken Pharmaceutical Co's annual raw materials declined from Mar. 2021 (円6,371 Mil) to Mar. 2022 (円6,209 Mil) but then increased from Mar. 2022 (円6,209 Mil) to Mar. 2023 (円6,348 Mil).


Kaken Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Kaken Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Inventories, Raw Materials & Components Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,959.00 4,683.00 6,371.00 6,209.00 6,348.00

Kaken Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,032.00 6,348.00 7,029.00 7,165.00 7,347.00

Kaken Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry
Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines